Insulin Resistance: Clinical Trials

4,731 trials for Insulin Resistance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3092 completed, 668 unknown, 364 recruiting, 193 terminated. 2527 Not applicable, 455 Phase 2, 398 Phase 4, 273 Phase 3, 214 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2527Completed 1700, Unknown 317, Recruiting 206, Active not recruiting 86, Terminated 82, Not yet recruiting 61, Withdrawn 50, Enrolling by invitation 16, Suspended 9
Phase 2455Completed 318, Unknown 40, Terminated 29, Recruiting 28, Withdrawn 22, Not yet recruiting 13, Active not recruiting 4, Suspended 1
Phase 4398Completed 272, Unknown 60, Terminated 33, Recruiting 16, Not yet recruiting 7, Withdrawn 7, Active not recruiting 2, Enrolling by invitation 1
Phase 3273Completed 190, Unknown 34, Terminated 16, Recruiting 10, Withdrawn 9, Active not recruiting 6, Not yet recruiting 5, Enrolling by invitation 2, Suspended 1
Phase 1214Completed 153, Recruiting 16, Unknown 16, Terminated 12, Withdrawn 8, Active not recruiting 5, Not yet recruiting 4
Early Phase 163Completed 39, Unknown 7, Recruiting 5, Not yet recruiting 4, Withdrawn 4, Active not recruiting 1, Enrolling by invitation 1, Suspended 1, Terminated 1

Follow Insulin Resistance: new trials by email Literature Review of Insulin Resistance trials Research Report on Insulin Resistance

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance
Vigabatrin Pill, Placebo oral tablet - Hyperinsulinism, Insulin Resistance
Phase 2WithdrawnUniversity of Arizona2030-04-152025-07-30
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
Caloric Restriction, Hyperglycemic clamp - Type2diabetes
Phase 2Not yet recruitingAdrian Vella202027-12-152026-10-28
Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus
Semaglutide (Wegovy) weekly injection - Gestational Diabetes Mellitus (GDM), Metabolic Syndrome
Phase 2 / Phase 3Not yet recruitingUniversity of Massachusetts, Worcester2262027-09-012026-09-28
cfMSC Therapy for Diabetes
cfMSC therapy for diabetes - Type II Diabetes Mellitus
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-11-02
Assessing Trauma-related Links Between Affective and Metabolic Systems
prazosin - Posttraumatic Stress Disorder, Metabolic Syndrome
Phase 4Not yet recruitingVA Office of Research and Development702027-03-012026-10-15
The Simplified Total-body Resistance Exercise for Muscular Hypertrophy for Diabetic Population (D-STORM)
D-STORM Resistance Training Programme, usual care - Type 2 Diabetes Mellitus (T2DM), Sarcopenia
Not applicableNot yet recruitingUniversiti Teknologi Mara562027-01-012026-06-25
Endoscopic Band Ligation for Type 2 Diabetes Mellitus (ENDOBAND-DM)
Endoscopic Band Ligation (ENDOBAND-DM) - Type 2 Diabetes Mellitus (T2DM)
Not applicableNot yet recruitingEl Katib Hospital102027-01-012026-09-10
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Insulin human, Octreotide Acetate, Glucagon - Insulin Resistance, Hyperinsulinemia
Phase 1Not yet recruitingColumbia University362027-01-012026-02-06
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Semaglutide + TAU, Placebo + TAU - Schizophrenia Disorder, Metabolic Syndrome
Phase 3Not yet recruitingAll India Institute of Medical Sciences, Bhubaneswar6002026-12-012026-08-18
Peripheral Vascular Effects of Insulin in Obesity
human insulin - Obesity (BMI>30), Insulin Resistance
Early Phase 1Not yet recruitingUniversity of Missouri-Columbia642026-12-012026-10-15
VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway
Vericiguat 10 MG, Placebo, Insulin Sensitivity Test - Cardiovascular Diseases, Insulin Sensitivity/Resistance
Phase 2Not yet recruitingUniversity of Alabama at Birmingham2002026-12-012026-01-23
Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity
human insulin - Obesity (BMI>30), Insulin Resistance
Early Phase 1Not yet recruitingUniversity of Missouri-Columbia642026-12-012026-10-15
IGOB131 As A GLP-1 Modulator For Metabolic Disorders In Adults With Obesity
IGOB131, Dextrin - Obesity & Overweight
Phase 2Not yet recruitingUniversity of Yaounde 1802026-12-012026-10-20
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
Urolithin A, Placebo - Healthy Volunteer
Not applicableRecruitingNational Institute on Aging (NIA)1802026-11-052026-11-02
Effects of Meal Macronutrients on Postprandial Lipids
High carb then high fat breakfast, High fat then high carb breakfast - Nephrotic Syndrome, Lipodystrophy
Phase 2Not yet recruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1002026-11-052026-11-02
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
Alpha-lipoic acid, Mirabegron, Placebo - Insulin Resistance, Obesity
Phase 2Not yet recruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)602026-11-052026-11-02
Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease
Empagliflozin, Insulin, Insulin Placebo - Alzheimer Disease
Phase 2Not yet recruitingWake Forest University Health Sciences302026-11-012026-09-30
Whole-Food Magnesium for Mental and Cardiometabolic Health
Low-Dose Whole-Food-Based Magnesium Supplement, Moderate-Dose Whole-Food-Based Magnesium Supplement, Placebo - Elevated Blood Glucose
Not applicableNot yet recruitingGeorge Mason University452026-11-012026-10-08
Metabolic Surgery for Atrial Fibrillation Elimination
Roux-en-Y Gastric Bypass or Sleeve Gastrectomy, Anti-Obesity Medication (AOM) treatment - Atrial Fibrillation, Obesity and Obesity-related Medical Conditions
Phase 4Not yet recruitingAli Aminian1002026-11-012026-04-17
Human Cerebrovascular Blood Flow and Sex Differences in Metabolic Syndrome
Indomethacin, Placebo, MRI - Metabolic Syndrome
Early Phase 1Not yet recruitingUniversity of Wisconsin, Madison722026-11-012026-11-02

Showing 20 of 4731. Sign in to see all of them.

Narrower conditions

Metabolic Syndrome (2093)  ·  Obesity (1187)  ·  Diabetes Mellitus, Type 2 (724)  ·  Diabetes Mellitus (645)  ·  Overweight (317)  ·  Motor Activity (276)  ·  Cardiovascular Diseases (274)  ·  Inflammation (267)  ·  Hypertension (262)  ·  Glucose Intolerance (204)  ·  Prediabetic State (192)  ·  Diabetes Mellitus, Type 1 (181)  ·  Non-alcoholic Fatty Liver Disease (166)  ·  Dyslipidemias (157)

Broader conditions

Nutritional and Metabolic Diseases (4722)  ·  Hyperinsulinism (4681)  ·  Glucose Metabolism Disorders (4672)  ·  Metabolic Diseases (4632)  ·  Pathological Conditions, Signs and Symptoms (1899)  ·  Endocrine System Diseases (1694)  ·  Signs and Symptoms (1563)  ·  Nutrition Disorders (1413)  ·  Body Weight (1396)  ·  Overnutrition (1379)  ·  Overweight (1065)  ·  Diabetes Mellitus (868)  ·  Pathologic Processes (533)  ·  Behavior (468)

Interventions

Exercise (211)  ·  Metformin (185)  ·  Insulin (162)  ·  Diet (67)  ·  Pioglitazone (62)  ·  Insulin Glargine (55)  ·  Cholecalciferol (42)  ·  Rosiglitazone (37)  ·  High-Intensity Interval Training (35)  ·  Insulin Lispro (35)  ·  Sodium Chloride (35)  ·  Insulin Aspart (33)  ·  Glucose (32)  ·  Glucose Tolerance Test (30)  ·  Caloric Restriction (28)

Sponsors

University of Aarhus (55)  ·  Massachusetts General Hospital (54)  ·  Maastricht University Medical Center (52)  ·  University of Copenhagen (51)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (42)  ·  Pennington Biomedical Research Center (39)  ·  Stanford University (38)  ·  Cairo University (34)  ·  Laval University (33)  ·  Washington University School of Medicine (32)  ·  Mayo Clinic (30)  ·  University of Alabama at Birmingham (29)  ·  University of Colorado, Denver (29)  ·  University of Toronto (29)  ·  University of California, San Francisco (27)

Countries

United States (1565)  ·  Canada (293)  ·  Denmark (208)  ·  China (168)  ·  Italy (163)  ·  Germany (157)  ·  United Kingdom (150)  ·  Spain (139)  ·  France (137)  ·  Netherlands (137)  ·  Taiwan (101)  ·  Turkey (Türkiye) (92)  ·  Mexico (89)  ·  South Korea (88)  ·  Sweden (81)

Top investigators

Joshua R Cook, MD, PhD (10)  ·  Kazuoki Kondo, MD (10)  ·  Michael Roden, Prof., MD (10)  ·  Samuel Klein, MD (10)  ·  Steven J Russell, MD, PhD (10)  ·  David JA Jenkins, MD, PhD, DSc (8)  ·  John L Sievenpiper, MD, PhD (7)  ·  Russell J de Souza, ScD, RD (7)  ·  Bruno Geloneze, MD, PhD (6)  ·  Jack A Yanovski, M.D. (6)  ·  John P Thyfault, PhD (6)

Results publications

PMID 33512717, PMID 37526194, PMID 31004409, PMID 10480510, PMID 18820647, PMID 24191286, PMID 25527677, PMID 27524654, PMID 32449201, PMID 33210751, PMID 37595266, PMID 37735841, PMID 10205010, PMID 11289482, PMID 12485966, PMID 14688154, PMID 15572438, PMID 16183552, PMID 16338915, PMID 16636217, PMID 16775236, PMID 17245174, PMID 17443373, PMID 17666313, PMID 18175740, PMID 18305915, PMID 18557952, PMID 19125756, PMID 19475464, PMID 19723613, PMID 19805654, PMID 19889232, PMID 20024643, PMID 20208057, PMID 20826632, PMID 21070531, PMID 21668975, PMID 21694556, PMID 21737826, PMID 21781358, PMID 21865361, PMID 22090467, PMID 22311420, PMID 22719806, PMID 22773702, PMID 22990269, PMID 23052794, PMID 23633524, PMID 24205974, PMID 24212451

NIH funding

2005 (7), 2019 (7), 2008 (5), 2014 (5), 2009 (4), 2015 (4), 2016 (4), 2025 (4), R01DK077966 (4), 2017 (3), 2018 (3), K12DK133995 (3), K23DK140614 (3), P20GM109096 (3), P30DK063608 (3)